An examination of decades of research suggests that immune system imbalances may trigger and sustain depressive symptoms, particularly in high-risk groups. This research paves the way for ...

Scientific advances in understanding the immune system are driving renewed interest in autoimmune diseases, with insights now being applied to autoimmune disorders like systemic lupus erythematosus ...

Teaming up with China-based Leads Biolabs, the partners are launching Oblenio Bio to develop a tri-specific T-cell engager antibody for autoimmune diseases. Leads is giving Oblenio the exclusive ...

The move will allow the company to focus on the commercialization of its lupus nephritis drug Lupkynis and the development of AUR200, an autoimmune disease candidate that Aurinia recently salvaged ...

The global drug-induced immune hemolytic anemia market, valued at approximately USD 7.8 billion in 2023, is poised for substantial growth and is projected to reach USD 13.4 billion by 2033. This ...

In a tough fundraising space, cell therapy biotechs pursuing autoimmune indications review staffing to ensure the right expertise is in place to tackle the new disease area. As cell therapy biotechs ...

Ancient immune defense system plays an unexpected role in cancer Date: November 5, 2024 Source: Memorial Sloan Kettering Cancer Center Summary: Along with defending against pathogens, the body's ...

Along with defending against pathogens, the body's innate immune system helps to protect the stability of our genomes in unexpected ways—ways that have important implications for the development ...

IN patients with severe chronic anemia, whether or not it is amenable to treatment with specific therapy, the administration of blood transfusions is often necessary to provide immediate ...

Sana will seek partners for both drugs while prioritizing spending on research in B-cell associated autoimmune diseases and Type 2 diabetes. Alongside those changes, Sana will also cut staff.